Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial "TRANSACT"

Not yet recruiting

Phase 3 Results N/A

Summary of Purpose

This study aims to explore the effectiveness of tranexamic acid (also known as trans amine or TXA) in reducing hematoma expansion in patients with hemorrhagic stroke when given in the acute phase. METHODOLOGY This will be a Phase III, parallel-group double-blind randomised placebo control trial. Patients allocated to the control group will receive standard care for hemorrhagic stroke according to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 February 2017.

1 Apr 2017 26 Jan 2017 30 Jun 2019 31 Dec 2019 1 Feb 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts